跳至主要内容
临床试验/NL-OMON21200
NL-OMON21200已完成Unknown

A feasibility study of a SDM intervention for the decision making process in advanced Parkinson’s disease

Radboud Institute for Health Sciences, Department of Neurology0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
Unknown
状态
已完成
发起方
入组人数
40

研究概览

简要总结

not applicable

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 64(—)

入选标准

  • Five hospitals will participate and are selected from our previous studies. Specialised neurology centers and community based hospitals will be represented, because they have differential access to advanced PD treatments. Neurologists in these hospitals will be eligible if they (1) consider at least five PD patients per year for advanced treatment; and (2) collaborate with a PD nurse specialist in the same hospital. We aim for a total of five to ten neurologists, each participating centre may provide more than one neurologist. Moreover, we aim to include professionals with different levels of expertise on the advanced treatment options. Patients may be included if they: 1) are diagnosed with advanced PD and are considered for advanced treatment, judged by their own neurologist; and 2) are eligible for all three treatments at the beginning of the decision-making process.

排除标准

  • Exclusion criteria for patients are: Current or previous advanced treatment for Parkinson's Disease

研究者

发起方
Radboud Institute for Health Sciences, Department of Neurology

相似试验